SMTL ID : 6oqi.1

CDK2 in complex with Cpd14 (5-fluoro-4-(4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl)-N-(5-(4-methylpiperazin-1-yl)pyridin-2-yl)pyrimidin-2-amine)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x N14: 5-fluoro-N-[5-(4-methylpiperazin-1-yl)pyridin-2-yl]-4-[(4S)-4-methyl-5,6,7,8-tetrahydro-4H-pyrazolo[1,5-a]azepin-3-yl]pyrimidin-2-amine(Non-covalent)

N14.1: 15 residues within 4Å: Chain A: I.11, G.12, G.14, V.19, A.32, V.65, F.81, E.82, F.83, L.84, D.87, Q.132, N.133, L.135, D.146 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.11, A:V.19 Hydrogen bonds: A:L.84, A:L.84 Water bridges: A:K.34 Salt bridges: A:D.87

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Bronner, S.M. et al., Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. Bioorg.Med.Chem.Lett. (2019)

Release Date

2020-07-29

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2

Related Entries With Identical Sequence